CND day 3 – Plenary, Availability of controlled substances for medical and scientific purposes : UK

We welcome this report. We will work towards strengthening an evidence based approach and promoting transparency in the pharmaceutical industry. INCB will also need to consider developing their own capacity to providing support for poorer countries.

Leave a Reply

Your email address will not be published. Required fields are marked *